{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:49:25Z","timestamp":1786121365664,"version":"build-2736575974"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100024370","name":"Government of Italy Ministry of Education University and Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024370","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.neuropharm.2026.111123","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T06:43:30Z","timestamp":1785393810000},"page":"111123","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Presynaptic release-regulating C5a receptors in the spinal cord of healthy mice and of animals suffering from experimental autoimmune encephalomyelitis: impact of the C5aR antagonist DF2593A"],"prefix":"10.1016","volume":"299","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-6716-8743","authenticated-orcid":false,"given":"Nicole","family":"Rosenwasser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4033-2194","authenticated-orcid":false,"given":"Veronica","family":"Torre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4463-6417","authenticated-orcid":false,"given":"Paride","family":"Saccani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guendalina","family":"Olivero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Boccella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5959-4443","authenticated-orcid":false,"given":"Laura","family":"Brandolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4011-1165","authenticated-orcid":false,"given":"Anna","family":"Pittaluga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2026.111123_bib1","doi-asserted-by":"crossref","DOI":"10.1111\/j.1471-4159.2008.05668.x","article-title":"The complement cascade: Yin-yang in neuroinflammation - neuro-protection and -degeneration","author":"Alexander","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2026.111123_bib2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jneuroim.2009.01.026","article-title":"CD4 microglial expression correlates with spontaneous clinical improvement in the acute Lewis rat EAE model","volume":"209","author":"Almolda","year":"2009","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.neuropharm.2026.111123_bib3","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1074\/jbc.M210120200","article-title":"Phosphorylation of key serine residues is required for internalization of the complement 5a (C5a) anaphylatoxin receptor via a \u03b2-arrestin, dynamin, and clathrin-dependent pathway","volume":"278","author":"Braun","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2026.111123_bib4","doi-asserted-by":"crossref","DOI":"10.1111\/imm.13929","article-title":"The contribution of complement system in multiple sclerosis: mechanisms and therapeutic potentials","author":"Cao","year":"2025","journal-title":"Immunology"},{"key":"10.1016\/j.neuropharm.2026.111123_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.coph.2011.10.010","article-title":"Metabotropic glutamate receptors and the control of chronic pain","author":"Chiechio","year":"2012","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.111123_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.586521","article-title":"Antibodies against the NH2-Terminus of the GluA subunits affect the AMPA-evoked releasing activity: the role of complement","volume":"12","author":"Cisani","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neuropharm.2026.111123_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.01108","article-title":"Acute low dose of trazodone recovers glutamate release efficiency and mGlu2\/3 autoreceptor impairments in the spinal cord of rats suffering from chronic sciatic ligation","volume":"11","author":"Cisani","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.111123_bib8","author":"Constantinescu"},{"key":"10.1016\/j.neuropharm.2026.111123_bib9","doi-asserted-by":"crossref","DOI":"10.1186\/1742-2094-6-34","article-title":"The C5a anaphylatoxin receptor CD88 is expressed in presynaptic terminals of hippocampal mossy fibres","volume":"6","author":"Crane","year":"2009","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuropharm.2026.111123_bib10","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jneuroim.2008.06.040","article-title":"Complement C5 regulates the expression of insulin-like growth factor binding proteins in chronic experimental allergic encephalomyelitis","volume":"203","author":"Cudrici","year":"2008","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.neuropharm.2026.111123_bib11","doi-asserted-by":"crossref","DOI":"10.1038\/s41582-020-0400-0","article-title":"Complement in neurological disorders and emerging complement-targeted therapeutics","author":"Dalakas","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neuropharm.2026.111123_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2016.05.009","article-title":"Neuronal vs glial glutamate uptake: resolving the conundrum","author":"Danbolt","year":"2016","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2026.111123_bib13","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.neuropharm.2013.07.037","article-title":"CCL5-glutamate interaction in central nervous system: early and acute presynaptic defects in EAE mice","volume":"75","author":"Di Prisco","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.111123_bib14","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1038\/nprot.2008.171","article-title":"A rapid percoll gradient procedure for preparation of synaptosomes","volume":"3","author":"Dunkley","year":"2008","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.neuropharm.2026.111123_bib15","doi-asserted-by":"crossref","first-page":"5764","DOI":"10.4049\/jimmunol.170.11.5764","article-title":"Complement C5a receptor-mediated signaling may be involved in neurodegeneration in alzheimer's disease","volume":"170","author":"Farkas","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.neuropharm.2026.111123_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/S1474-4422(15)00393-2","article-title":"MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines","author":"Filippi","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuropharm.2026.111123_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.molimm.2004.06.011","article-title":"Complement: a unique innate immune sensor for danger signals","author":"Gasque","year":"2004","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.neuropharm.2026.111123_bib18","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1111\/j.1471-4159.2004.02942.x","article-title":"Identification of complement 5a-like receptor (C5L2) from astrocytes: characterization of anti-inflammatory properties","volume":"92","author":"Gavrilyuk","year":"2005","journal-title":"J. Neurochem."},{"issue":"2\u20133","key":"10.1016\/j.neuropharm.2026.111123_bib19","first-page":"163","article-title":"Cellular distribution and kinetic properties of high-affinity glutamate transporters","volume":"37","author":"Gegelashvili","year":"1998","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2026.111123_bib20","doi-asserted-by":"crossref","DOI":"10.1134\/S0006297922090012","article-title":"Astrocyte activation markers","author":"Gorina","year":"2022","journal-title":"Biochemistry (Mosc.)"},{"key":"10.1016\/j.neuropharm.2026.111123_bib21","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.neuropharm.2003.09.012","article-title":"Somatostatin inhibits glutamate release from mouse cerebrocortical nerve endings through presynaptic sst2 receptors linked to the adenylyl cyclase-protein kinase a pathway","volume":"46","author":"Grilli","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.111123_bib22","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1742-2094-8-80","article-title":"Increased local concentration of complement C5a contributes to incisional pain in mice","volume":"8","author":"Jang","year":"2011","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuropharm.2026.111123_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.tins.2020.10.003","article-title":"Neuroprotective versus neuroinflammatory roles of complement: from development to disease","author":"Kanmogne","year":"2021","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111123_bib24","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1124\/jpet.105.099630","article-title":"The human immunodeficiency virus-1 protein transactivator of transcription up-regulates N-methyl-D-aspartate receptor function by acting at metabotropic glutamate receptor 1 receptors coexisting on human and rat brain noradrenergic neurones","volume":"317","author":"Longordo","year":"2006","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2026.111123_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.00023","article-title":"Complement system in brain architecture and neurodevelopmental disorders","author":"Magdalon","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111123_bib26","doi-asserted-by":"crossref","first-page":"884","DOI":"10.3390\/toxins3070884","article-title":"Gi\/o protein-dependent and -independent actions of pertussis toxin (ptx)","volume":"3","author":"Mangmool","year":"2011","journal-title":"Toxins"},{"key":"10.1016\/j.neuropharm.2026.111123_bib27","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/jnc.12650","article-title":"Complement selectively elicits glutamate release from nerve endings in different regions of mammal central nervous system","volume":"129","author":"Merega","year":"2014","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2026.111123_bib28","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s40478-018-0536-y","article-title":"Systemic inhibition of the membrane attack complex impedes neuroinflammation in chronic relapsing experimental autoimmune encephalomyelitis","volume":"6","author":"Michailidou","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.neuropharm.2026.111123_bib29","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/ana.24398","article-title":"Complement C1q-C3-associated synaptic changes in multiple sclerosis hippocampus","volume":"77","author":"Michailidou","year":"2015","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2026.111123_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/sj.bjp.0707332","article-title":"Function, structure and therapeutic potential of complement C5a receptors","author":"Monk","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.111123_bib31","doi-asserted-by":"crossref","first-page":"16937","DOI":"10.1073\/pnas.1417365111","article-title":"Targeting the minor pocket of C5aR for the rational design of an oral allosteric inhibitor for inflammatory and neuropathic pain relief","volume":"111","author":"Moriconi","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2026.111123_bib32","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.expneurol.2012.12.012","article-title":"Changes in nociceptive sensitivity and object recognition in experimental autoimmune encephalomyelitis (EAE)","volume":"241","author":"Olechowski","year":"2013","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2026.111123_bib33","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.neuropharm.2018.02.030","article-title":"5-HT2A-mGlu2\/3 receptor complex in rat spinal cord glutamatergic nerve endings: a 5-HT2A to mGlu2\/3 signalling to amplify presynaptic mechanism of auto-control of glutamate exocytosis","volume":"133","author":"Olivero","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.111123_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241914905","article-title":"Anti-NMDA and Anti-AMPA receptor antibodies in central disorders: preclinical approaches to assess their pathological role and translatability to clinic","author":"Olivero","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2026.111123_bib35","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1111\/bph.16328","article-title":"Complement tunes glutamate release and supports synaptic impairments in an animal model of multiple sclerosis","volume":"181","author":"Olivero","year":"2024","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.111123_bib36","doi-asserted-by":"crossref","first-page":"6142","DOI":"10.1007\/s12035-019-1511-8","article-title":"Immuno-pharmacological characterization of presynaptic GluN3A-Containing NMDA autoreceptors: relevance to Anti-NMDA receptor autoimmune diseases","volume":"56","author":"Olivero","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2026.111123_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20153641","article-title":"Acute functional adaptations in isolated presynaptic terminals unveil synaptosomal learning and memory","author":"Pittaluga","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2026.111123_bib38","doi-asserted-by":"crossref","DOI":"10.2174\/011570159X327960240823065729","article-title":"Non-canonical roles of complement in the CNS: from synaptic organizer to presynaptic modulator of glutamate transmission","author":"Pittaluga","year":"2025","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.neuropharm.2026.111123_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.biochi.2007.02.015","article-title":"The N-formyl peptide receptors and the anaphylatoxin C5a receptors: an overview","author":"Rabiet","year":"2007","journal-title":"Biochimie"},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111123_bib40","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0014-2999(74)90272-6","article-title":"A simple apparatus for studying the release of neurotransmitters from synaptosomes","volume":"25","author":"Raiteri","year":"1974","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.111123_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.970486","article-title":"The role of the complement system in multiple sclerosis: a review","author":"Saez-Calveras","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neuropharm.2026.111123_bib42","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-020-02024-8","article-title":"The good, the bad, and the opportunities of the complement system in neurodegenerative disease","author":"Schartz","year":"2020","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111123_bib43","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/0889-1591(89)90003-2","article-title":"Binding specificity and presynaptic action of anaphylatoxin C5a in rat brain","volume":"3","author":"Schupf","year":"1989","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuropharm.2026.111123_bib44","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1016\/j.jid.2021.12.029","article-title":"C5aR2 deficiency ameliorates inflammation in murine epidermolysis bullosa acquisita by regulating Fc\u03b3 receptor expression on neutrophils","volume":"142","author":"Seiler","year":"2022","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.neuropharm.2026.111123_bib45","doi-asserted-by":"crossref","DOI":"10.1172\/JCI163105","article-title":"C5aR1 signaling triggers lung immunopathology in COVID-19 through neutrophil extracellular traps","volume":"133","author":"Silva","year":"2023","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.neuropharm.2026.111123_bib46","doi-asserted-by":"crossref","first-page":"49403","DOI":"10.1074\/jbc.M209672200","article-title":"Identification of a potent and orally active non-peptide C5a receptor antagonist","volume":"277","author":"Sumichika","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2026.111123_bib47","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.2147\/NDT.S359620","article-title":"Association of pain with plasma C5a in patients with neuromyelitis optica spectrum disorders during remission","volume":"18","author":"Tong","year":"2022","journal-title":"Neuropsychiatric Dis. Treat."},{"key":"10.1016\/j.neuropharm.2026.111123_bib48","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jpain.2004.11.011","article-title":"Activation of the spinal cord complement Cascade might contribute to mechanical allodynia induced by three animal models of spinal sensitization","volume":"6","author":"Twining","year":"2005","journal-title":"J. Pain"},{"key":"10.1016\/j.neuropharm.2026.111123_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.molimm.2011.04.003","article-title":"Complement in the brain","author":"Veerhuis","year":"2011","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.neuropharm.2026.111123_bib50","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s12017-009-8085-y","article-title":"The role of the complement system and the activation fragment C5a in the central nervous system","volume":"12","author":"Woodruff","year":"2010","journal-title":"Neuromolecular Med."},{"key":"10.1016\/j.neuropharm.2026.111123_bib51","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1182\/blood-2005-04-1496","article-title":"Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy","volume":"106","author":"Zappia","year":"2005","journal-title":"Blood"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826002984?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826002984?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T04:25:52Z","timestamp":1786076752000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390826002984"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":51,"alternative-id":["S0028390826002984"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.111123","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Presynaptic release-regulating C5a receptors in the spinal cord of healthy mice and of animals suffering from experimental autoimmune encephalomyelitis: impact of the C5aR antagonist DF2593A","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.111123","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111123"}}